Adults 20 to 75, any sex, with Rotator Cuff Tendinosis. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Change in Pain Visual Analogue Scale(VAS)Primary· baseline, immediate after treatment, 4 weeks, 12 weeks
The Visual Analog Scale (VAS) was used to measure pain intensity. The scale ranges from 0 to 10, where 0 indicates no pain and 10 represents the worst possible pain. Higher scores indicate worse outcomes.
baseline
Group
Value
95% CI
Physiotherapy and High-PEMF
5.91
± 2.51
Physiotherapy and Sham High-PEMF
5.90
± 1.91
immediate after treatment
Group
Value
95% CI
Physiotherapy and High-PEMF
4.73
± 2.37
Physiotherapy and Sham High-PEMF
4.60
± 2.27
4 weeks
Group
Value
95% CI
Physiotherapy and High-PEMF
3.55
± 1.69
Physiotherapy and Sham High-PEMF
4.90
± 1.52
12 weeks
Group
Value
95% CI
Physiotherapy and High-PEMF
3.72
± 2.61
Physiotherapy and Sham High-PEMF
3.50
± 1.27
Change in Total Score of Shoulder Pain and Disability Index (SPADI)Secondary· baseline, immediate after treatment, 4 weeks, 12 weeks
The Shoulder Pain and Disability Index (SPADI) is a patient completed questionnaire with 13 items assessing pain level and extent of difficulty with activity of daily livings (ADLs) requiring the use of the upper extremities. The pain subscale has 5-items and the Disability subscale has 8-items. The patient is instructed to choose the number that best describes their level of pain and extent of difficulty using the involved shoulder. The pain scale is summed up to a total of 50 while the disability scale sums up to 80.
The total SPADI score is calculated by adding the scores of the Pain and D
baseline
Group
Value
95% CI
Physiotherapy and High-PEMF
58.27
± 22.85
Physiotherapy and Sham High-PEMF
65.80
± 32.25
immediate after treatment
Group
Value
95% CI
Physiotherapy and High-PEMF
39.18
± 25.13
Physiotherapy and Sham High-PEMF
52.40
± 26.83
4 weeks
Group
Value
95% CI
Physiotherapy and High-PEMF
41.27
± 30.21
Physiotherapy and Sham High-PEMF
60.20
± 41.16
12 weeks
Group
Value
95% CI
Physiotherapy and High-PEMF
33.27
± 21.28
Physiotherapy and Sham High-PEMF
30.80
± 33.27
Changes of Shoulder Range of Motion in Active FlexionSecondary· baseline, immediate after treatment, 4 weeks, 12 weeks
Shoulder ROM during flexion, abduction in the sitting position, internal rotation (IR) at 90° of abduction of the affected shoulder were measured using a digital goniometer, and the mean of three values was used for analysis
baseline
Group
Value
95% CI
Physiotherapy and High-PEMF
143.74
± 20.18
Physiotherapy and Sham High-PEMF
154.11
± 23.47
immediately
Group
Value
95% CI
Physiotherapy and High-PEMF
147.76
± 19.81
Physiotherapy and Sham High-PEMF
152.53
± 24.93
4 weeks
Group
Value
95% CI
Physiotherapy and High-PEMF
144.89
± 21.66
Physiotherapy and Sham High-PEMF
149.79
± 24.70
12 weeks
Group
Value
95% CI
Physiotherapy and High-PEMF
148.25
± 22.54
Physiotherapy and Sham High-PEMF
159.29
± 25.29
Changes of Shoulder Range of Motion in Active AbductionSecondary· baseline, immediately after treatment, 4 weeks, 12 weeks
Shoulder ROM during flexion, abduction in the sitting position, internal rotation (IR) at 90° of abduction of the affected shoulder were measured using a digital goniometer, and the mean of three values was used for analysis
baseline
Group
Value
95% CI
Physiotherapy and High-PEMF
142.51
± 24.13
Physiotherapy and Sham High-PEMF
153.79
± 26.34
immediately
Group
Value
95% CI
Physiotherapy and High-PEMF
147.16
± 24.78
Physiotherapy and Sham High-PEMF
154.22
± 29.54
4 weeks
Group
Value
95% CI
Physiotherapy and High-PEMF
152.93
± 27.24
Physiotherapy and Sham High-PEMF
153.00
± 28.30
12 weeks
Group
Value
95% CI
Physiotherapy and High-PEMF
149.74
± 25.48
Physiotherapy and Sham High-PEMF
163.34
± 27.59
Changes of Shoulder Range of Motion in Active Internal RotationSecondary· baseline, immediately after treatment, 4 weeks, 12 weeks
Shoulder ROM during flexion, abduction in the sitting position, internal rotation (IR) at 90° of abduction of the affected shoulder were measured using a digital goniometer, and the mean of three values was used for analysis
baseline
Group
Value
95% CI
Physiotherapy and High-PEMF
60.75
± 18.71
Physiotherapy and Sham High-PEMF
73.03
± 15.41
immediately
Group
Value
95% CI
Physiotherapy and High-PEMF
68.46
± 18.68
Physiotherapy and Sham High-PEMF
73.33
± 14.33
4 weeks
Group
Value
95% CI
Physiotherapy and High-PEMF
71.19
± 15.56
Physiotherapy and Sham High-PEMF
80.94
± 7.29
12 weeks
Group
Value
95% CI
Physiotherapy and High-PEMF
76.66
± 12.36
Physiotherapy and Sham High-PEMF
81.79
± 11.29
Sponsor's own description
The aim of our study is to investigate the efficacy of high energy density pulse electromagnetic field for patients with rotator cuff tendinopathy
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Other trials of High energy density pulse electromagnetic field
Trials testing the same drug.
NCT06000254 — High Energy Density Pulse Electromagnetic Field for Patients With Adhensive Capsulitis
· NA
· completed
NCT05979974 — High Energy Density Pulse Electromagnetic Field for Patients With Frozen Shoulder
· NA
· terminated
Other recruiting trials for Rotator Cuff Tendinosis
Currently open trials in the same condition.
NCT06095050 — Embolization Treatment of Chronic Refractory Shoulder Tendinopathy
· NA
· recruiting
NCT06160427 — Connective Tissue Matrix for Rotator Cuff Tendinopathy
· Phase 4
· active not recruiting
NCT04923477 — Therapeutic Exercise for Rotator Cuff Tendinopathy / Subacromial Pain Syndrome - Outcomes and Mechanisms
· NA
· recruiting
Other Tri-Service General Hospital trials
Trials by the same sponsor.
NCT07515495 — Effectiveness of Intensive Tutoring vs. Flexible Self-Learning on Digital Health Literacy and Self-Efficacy for "My Heal
· NA
· recruiting
NCT07589322 — Comparative Observation of Metabolic and Pharmacologic Adipose Remodeling With Enhanced Incretin AgonisTs
· NA
· recruiting
NCT07327385 — To Investigate the Change of Brain and Autonomic Function From Different Protocols of Repeated Transcranial Magnetic Sti
· NA
· not yet recruiting
NCT07355023 — AI-Enabled Electrocardiogram-Guided Guideline-Directed Medical Therapy on Incident Left Ventricular Dysfunction: A Targe
· NA
· recruiting
NCT07241182 — Antrodia Cinnamomea Extract Effects on Lung Cancer Patients' Quality of Life During Chemotherapy
· NA
· recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tri-Service General Hospital
Last refreshed: 25 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05483517.